In addition, LA alone could inhibit the proliferation of bladder cancer cells, while SZY-200 downregulates the expressions of the peroxisome-proliferator-activated receptor gamma (PPAR-γ) and prostaglandin-endoperoxide synthase 2 (PTGS2) genes involved in the development of bladder cancer [27]. The gene discussed is PPARG; the disease is urinary bladder cancer.